Connecting Industries Worldwide

Johnson & Johnson Consumer Inc to acquire Zarbee's Inc

Johnson & Johnson Consumer Inc. has announced that it has entered into a definitive agreement to acquire Zarbee's, Inc., a privately held company that is a leader in naturally-based healthcare products.

The acquisition will include the full line of Zarbee's Naturals™ products for children and adults. Financial terms of the transaction were not disclosed.

Zarbee's Naturals™ was founded in 2008 by Dr Zak Zarbock, a paediatrician who was inspired to create safe, wholesome and effective alternatives to traditional OTC medicines. His first product was a honey-based kids' cough syrup made with vitamin C and zinc and free of alcohol, drugs, and artificial flavours. Over the last decade, Zarbee's Naturals™ has grown into a broad-based health and wellness brand and has disrupted the cough, sleep, immune support and vitamin categories with its portfolio of family-friendly products.

"Zarbee's is a values-driven company that was founded on and has achieved significant growth by meeting the evolving health needs of today's families," said Katie Devine, Global President, OTC Franchise, Johnson & Johnson Consumer Inc. "As a global OTC leader, Johnson & Johnson Consumer shares in this vision and is committed to providing innovative healthcare solutions that satisfy the preferences of consumers."

"Through Zarbee's Naturals™, we are excited to bring a more comprehensive set of products to consumers within our core need states," said Kathy Widmer, President, U.S. OTC, Johnson & Johnson Consumer Inc. "The Zarbee's team has achieved tremendous success in the marketplace and we are excited to be a part of their future growth. Upon closing of the transaction, we look forward to working closely with the Zarbee's team as they join the Johnson & Johnson Consumer family."

The closing of the transaction is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and other customary closing conditions. The transaction is expected to close during the third quarter of 2018.